UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

IBD barriers across the continents – East Asia

Therapeutic Advances in Gastroenterology, 2023-01, Vol.16, p.17562848231212089-17562848231212089

2023

Volltextzugriff (PDF)

Editorial: Treatments for inflammatory bowel disease across the age‐spectrum—Are they the same?

Alimentary pharmacology & therapeutics, 2024-08, Vol.60 (4), p.523-524

2024

Volltextzugriff (PDF)

Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome

Gut, 2022-03, Vol.71 (3), p.544

2022

Volltextzugriff (PDF)

No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?

Journal of rheumatology, 2020-10, Vol.47 (10), p.1591

2020

Volltextzugriff (PDF)

Epidemiology of fibrostenosing inflammatory bowel disease

Journal of digestive diseases, 2020-06, Vol.21 (6), p.332-335

2020

Volltextzugriff (PDF)

Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome

Nature communications, 2022-11, Vol.13 (1), p.6806-6806, Article 6806

2022

Volltextzugriff (PDF)

Zero COVID‐19 infection in inflammatory bowel disease patients: Findings from population‐based inflammatory bowel disease registries in Hong Kong and Taiwan

Journal of gastroenterology and hepatology, 2021-01, Vol.36 (1), p.171-173

2021

Volltextzugriff (PDF)

Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea

Alimentary pharmacology & therapeutics, 2023-10, Vol.58 (8), p.795-804

2023

Volltextzugriff (PDF)

Mixed-donor faecal microbiota transplantation was associated with increased butyrate-producing bacteria for obesity

Gut, 2023-03, Vol.73 (5), p.875

2023

Volltextzugriff (PDF)

Gut microbiome signatures reflect different subtypes of irritable bowel syndrome

Gut microbes, 2023-12, Vol.15 (1), p.2157697-2157697

2023

Volltextzugriff (PDF)

Incidence and clinical course of COVID-19 in patients with rheumatologic diseases: A population-based study

Seminars in arthritis and rheumatism, 2020-10, Vol.50 (5), p.885-889

2020

Volltextzugriff (PDF)

The gut microbiome associates with phenotypic manifestations of post-acute COVID-19 syndrome

Cell host & microbe, 2024-05, Vol.32 (5), p.651-660.e4

2024

Volltextzugriff (PDF)

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States

Clinical gastroenterology and hepatology, 2021-10, Vol.19 (10), p.2210-2213.e3

2021

Volltextzugriff (PDF)

Epidemiology and Natural History of Elderly-onset Inflammatory Bowel Disease: Results From a Territory-wide Hong Kong IBD Registry

Journal of Crohn's and colitis, 2021-03, Vol.15 (3), p.401-408

2021

Volltextzugriff (PDF)

Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium

Inflammatory bowel diseases, 2023-11, Vol.29 (11), p.1693-1705

2023

Volltextzugriff (PDF)

Stopping anti‐tumour necrosis factor therapy in patients with perianal Crohn’s disease

Alimentary pharmacology & therapeutics, 2019-12, Vol.50 (11-12), p.1195-1203

2019

Volltextzugriff (PDF)

TM9SF4 Is a Crucial Regulator of Inflammation and ER Stress in Inflammatory Bowel Disease

Cellular and molecular gastroenterology and hepatology, 2022-01, Vol.14 (2), p.245-270

2022

Volltextzugriff (PDF)

Antibiotics and probiotics impact gut antimicrobial resistance gene reservoir in COVID-19 patients

Gut microbes, 2022-12, Vol.14 (1), p.2128603-2128603

2022

Volltextzugriff (PDF)

Implications of the COVID-19 Pandemic on the Management of Inflammatory Bowel Disease in the Low Resource Countries of Asia

EMJ. Gastroenterology, 2022-03

2022

Volltextzugriff (PDF)

High prevalence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong

United European gastroenterology journal, 2021-11, Vol.9 (9), p.1027-1038

2021

Volltextzugriff (PDF)

Su1855 RISK OF HEPATITIS FLARE IN PATIENTS WITH PREVIOUS HEPATITIS B VIRUS EXPOSURE AMONGST INFLAMMATORY BOWEL DISEASE PATIENTS - RESULTS FROM A TERRITORY-WIDE HONG KONG IBD REGISTRY STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-676-S-676

2020

Volltextzugriff (PDF)

1275 GUT VIROME ASSOCIATED WITH IMPROVED ATHEROGENIC LIPOPROTEIN AND LIVER STEATOSIS AFTER FECAL MICROBIOTA TRANSPLANTATION IN OBESE SUBJECTS WITH TYPE 2 DIABETES

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-304-S-304

2024

Volltextzugriff (PDF)

EP1327: GUT MICROBIOME SIGNATURES REFLECT DIFFERENT SUBTYPES OF IRRITABLE BOWEL SYNDROME

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1102-S-1103

2022

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(25)
Gastroenterology & Hepatology
(21)
Humans
(21)
Covid-19
(9)
Female
(9)
Male
(9)
Adult
(8)
Middle Aged
(7)
Sars-Cov-2
(7)
Inflammatory Bowel Disease
(6)
Microbiota
(6)
Feces - Microbiology
(5)
Inflammatory Bowel Diseases
(5)
Aged
(4)
Inflammatory Bowel Diseases - Complications
(4)
Intestine
(4)
Metagenomics
(4)
Pandemics
(4)
Young Adult
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

IBD barriers across the continents – East Asia

Editorial: Treatments for inflammatory bowel disease across the age‐spectrum—Are they the same?

Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome

No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?

Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial

Epidemiology of fibrostenosing inflammatory bowel disease

Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome

Zero COVID‐19 infection in inflammatory bowel disease patients: Findings from population‐based inflammatory bowel disease registries in Hong Kong and Taiwan

Use of over-the-scope clip (OTSC) versus standard therapy for the prevention of rebleeding in large peptic ulcers (size ≥1.5 cm): an open-labelled, multicentre international randomised controlled trial

Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea

Mixed-donor faecal microbiota transplantation was associated with increased butyrate-producing bacteria for obesity

Gut microbiome signatures reflect different subtypes of irritable bowel syndrome

Incidence and clinical course of COVID-19 in patients with rheumatologic diseases: A population-based study

The gut microbiome associates with phenotypic manifestations of post-acute COVID-19 syndrome

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States

Epidemiology and Natural History of Elderly-onset Inflammatory Bowel Disease: Results From a Territory-wide Hong Kong IBD Registry

Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium

Stopping anti‐tumour necrosis factor therapy in patients with perianal Crohn’s disease

TM9SF4 Is a Crucial Regulator of Inflammation and ER Stress in Inflammatory Bowel Disease

Antibiotics and probiotics impact gut antimicrobial resistance gene reservoir in COVID-19 patients

Implications of the COVID-19 Pandemic on the Management of Inflammatory Bowel Disease in the Low Resource Countries of Asia

High prevalence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong

Su1855 RISK OF HEPATITIS FLARE IN PATIENTS WITH PREVIOUS HEPATITIS B VIRUS EXPOSURE AMONGST INFLAMMATORY BOWEL DISEASE PATIENTS - RESULTS FROM A TERRITORY-WIDE HONG KONG IBD REGISTRY STUDY

1275 GUT VIROME ASSOCIATED WITH IMPROVED ATHEROGENIC LIPOPROTEIN AND LIVER STEATOSIS AFTER FECAL MICROBIOTA TRANSPLANTATION IN OBESE SUBJECTS WITH TYPE 2 DIABETES

EP1327: GUT MICROBIOME SIGNATURES REFLECT DIFFERENT SUBTYPES OF IRRITABLE BOWEL SYNDROME

Suchergebnisse filtern